Oncology medical news

Headlines

23 Jan 2020 - UK Medical News Cancer-causing HPV infections have reached very low levels in England
This can be attributed to the high uptake of HPV vaccination.
23 Jan 2020 - UK Medical News Health in England outperforms US but lags behind Scandinavian countries
Data from the Global Burden of Disease study show there have been improvements, but there’s more left to do.
23 Jan 2020 - Oncology drug update NICE approves palbociclib with fulvestrant for HER2-negative breast cancer
The treatment will be available for use under the Cancer Drugs Fund

Latest Updates

24 Jan 2020 - UK Medical News Wuhan virus screening initiated at entry points in England
There are three direct flights a week that arrive at Heathrow from Wuhan.
24 Jan 2020 - Univadis Clinical Summaries from Lancet Oncol Ribociclib+letrozole downstages high-risk HR+ early breast cancer in phase 2
CORALLEEN trial suggests potential for chemo-free strategy.
24 Jan 2020 - Univadis Clinical Summaries from US Food and Drug Administration FDA gives nod to avapritinib for mutant GIST
The drug is the first therapy approved for GIST with PDGFRA exon 18 mutations.
24 Jan 2020 - Univadis Clinical Summaries from Int J Clin Oncol HRT use is associated with lower lung cancer risk in women
Association was found only in current HRT users and ever-smokers.
24 Jan 2020 - Univadis Clinical Summaries from Lancet Gastroenterol Hepatol Locally advanced pancreatic cancer: nab-paclitaxel+gemcitabine shows promise
No prospective data are available for this regimen or FOLFIRINOX in this population.
24 Jan 2020 - Oncology guidelines update from J Clin Oncol Optimum imaging strategies for advanced prostate cancer: ASCO guidelines
Imaging is recommended for all patients according to the clinical scenario.
23 Jan 2020 - Univadis Clinical Summaries from J Clin Oncol Breast cancer: updated ASCO/CAP guideline creates new category for low ER+ tumors
Samples with 1%-10% ER+ nuclei should be categorized as ER Low Positive with comments.
23 Jan 2020 - Univadis Clinical Summaries from J Natl Cancer Inst Rectal cancer: watchful waiting or surgery after complete clinical response?
Costs may improve with watchful waiting, but survival is lower.
23 Jan 2020 - Univadis Clinical Summaries from JAMA Oncol PDAC: DNA repair deficiency-targeted triple combo shows promise in early-phase trial
Complete response endpoint was not met; objective response rates were high.
23 Jan 2020 - Univadis Clinical Summaries from Int J Cancer Long-term follow-up reduces CRC risk after FOBT reveals high-risk adenoma
The study is the first to assess long-term CRC incidence in this population.
23 Jan 2020 - Univadis Medical News ESMO recommendations on the management of cardiac disease in cancer patients
The guidelines provide suggested strategies for the prevention, detection and treatment of cardiotoxicity.
22 Jan 2020 - UK Clinical Digest from J Pediatr Maternal infection during pregnancy and risk for childhood leukaemia
Results from a systematic review and meta-analysis.
22 Jan 2020 - Univadis Clinical Summaries from Eur Urol Active surveillance is safe in low-grade prostate cancer over the long term
15-year prostate cancer mortality was 0.1%.
22 Jan 2020 - Oncology drug update FDA approves pembrolizumab for high-risk bladder cancer
Approval was based on phase 2 KEYNOTE-057 study.

Related topics

You're leaving Univadis